Skip to NavigationSkip to content

AstraZeneca to switch entire fleet to electric vehicles by 2030

Published on 17/07/19 at 10:13am

AstraZeneca has revealed plans to use only electric vehicles by 2030.

In joining the EV100 group, AstraZeneca will transfer the entirety of its 16,000 strong fleet to electric vehicles.

The move is set to save 80,000 metric tonnes of CO2 each year. It is hoped the switch to electric will reduce the negative health impact of air pollution across the globe.

In joining EV100, whose members include BT, Unilever and the Bank of America, AstraZeneca will become the first pharmaceutical company to pledge its commitment to the group.

Helen Clarkson, CEO of The Climate Group, commented: “When a pharmaceutical company says we need to go electric to help everyone breathe clean air, every business with a fleet needs to listen.

“This is great example of a company addressing the global climate and air pollution crisis. As the first global healthcare company to flip its fleet through EV100, and the 50th large business to do so, AstraZeneca is setting a new benchmark in the drive to electric vehicles.”

Katarina Ageborg, EVP, Sustainability and Chief Compliance Officer, AstraZeneca, said: “Recognising the link between a healthy environment and human health, we believe that by investing in electric vehicles and emissions-reduction initiatives, we can help reduce the burden of respiratory diseases and other air pollution-related conditions. Environmental stewardship will prevent disease as well as protect the planet for future generations.

“Sustainable business is about addressing the impact of our activities on both the planet and on people’s health and this needs to be a joint effort. We should all work together in partnership on climate action.”

AstraZeneca is currently part of the RE100 group which sees companies pledge their commitment to sourcing energy only from renewables. The Anglo-Swedish multinational has thus pledged to use only renewable energy by 2020 in Europe and by 2025 in the United States.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches